tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

Amplia Therapeutics Announces Change in Substantial Holder Interests
Company AnnouncementsAmplia Therapeutics Announces Change in Substantial Holder Interests
11d ago
Amplia Therapeutics Achieves Rare Complete Response in Pancreatic Cancer Trial
PremiumCompany Announcements
Amplia Therapeutics Achieves Rare Complete Response in Pancreatic Cancer Trial
11d ago
Amplia Therapeutics Achieves Rare Complete Response in Pancreatic Cancer Trial
PremiumCompany Announcements
Amplia Therapeutics Achieves Rare Complete Response in Pancreatic Cancer Trial
14d ago
Amplia Therapeutics Releases 2025 Corporate Governance Statement
PremiumCompany Announcements
Amplia Therapeutics Releases 2025 Corporate Governance Statement
1M ago
Amplia Therapeutics Releases 2025 Corporate Governance Statement
PremiumCompany Announcements
Amplia Therapeutics Releases 2025 Corporate Governance Statement
1M ago
Amplia Therapeutics Releases 2025 Annual Report
PremiumCompany AnnouncementsAmplia Therapeutics Releases 2025 Annual Report
1M ago
Amplia Therapeutics’ ACCENT Trial Shows Promising Results in Pancreatic Cancer
Premium
Company Announcements
Amplia Therapeutics’ ACCENT Trial Shows Promising Results in Pancreatic Cancer
2M ago
Amplia Therapeutics Strengthens Leadership with New CMO Appointment Amidst Key Clinical Trials
Premium
Company Announcements
Amplia Therapeutics Strengthens Leadership with New CMO Appointment Amidst Key Clinical Trials
2M ago
Amplia Therapeutics’ ACCENT Trial Shows Promising Results in Pancreatic Cancer Treatment
PremiumCompany Announcements
Amplia Therapeutics’ ACCENT Trial Shows Promising Results in Pancreatic Cancer Treatment
2M ago
Amplia Therapeutics Launches US Trial for Innovative Pancreatic Cancer Treatment
PremiumCompany Announcements
Amplia Therapeutics Launches US Trial for Innovative Pancreatic Cancer Treatment
3M ago
Amplia Therapeutics Reports Promising Data from Pancreatic Cancer Trial
PremiumCompany Announcements
Amplia Therapeutics Reports Promising Data from Pancreatic Cancer Trial
3M ago
Amplia Therapeutics Advances US Clinical Trial Plans with FDA Approval
PremiumCompany Announcements
Amplia Therapeutics Advances US Clinical Trial Plans with FDA Approval
4M ago
Amplia Therapeutics Adjusts Option Exercise Prices Post Capital Raising
PremiumCompany AnnouncementsAmplia Therapeutics Adjusts Option Exercise Prices Post Capital Raising
5M ago
Amplia Therapeutics Completes Early Recruitment for Promising Pancreatic Cancer Trial
Premium
Company Announcements
Amplia Therapeutics Completes Early Recruitment for Promising Pancreatic Cancer Trial
5M ago
Amplia Therapeutics Advances Cancer Treatment with Promising Trial Results and Strategic Collaborations
Premium
Company Announcements
Amplia Therapeutics Advances Cancer Treatment with Promising Trial Results and Strategic Collaborations
5M ago
Amplia Therapeutics Unveils Promising Data for Narmafotinib at Keystone Meeting
PremiumCompany Announcements
Amplia Therapeutics Unveils Promising Data for Narmafotinib at Keystone Meeting
5M ago
Amplia Therapeutics Secures $13 Million in Capital Raise
PremiumCompany Announcements
Amplia Therapeutics Secures $13 Million in Capital Raise
6M ago
Amplia Therapeutics Announces Director’s Increased Shareholding
PremiumCompany Announcements
Amplia Therapeutics Announces Director’s Increased Shareholding
6M ago
Amplia Therapeutics Announces Director’s Share Acquisition
PremiumCompany Announcements
Amplia Therapeutics Announces Director’s Share Acquisition
6M ago
Amplia Therapeutics Announces Change in Director’s Interest
PremiumCompany AnnouncementsAmplia Therapeutics Announces Change in Director’s Interest
6M ago
Amplia Therapeutics Director Increases Stake, Boosting Investor Interest
Premium
Company Announcements
Amplia Therapeutics Director Increases Stake, Boosting Investor Interest
6M ago
Amplia Therapeutics Lists New Securities on ASX
Premium
Company Announcements
Amplia Therapeutics Lists New Securities on ASX
6M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >